Nasal Polyps: Clinical Trials

2 recruiting. 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	2	Recruiting 2

Follow Nasal Polyps: new trials by email Literature Review of Nasal Polyps trials Research Report on Nasal Polyps

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) GSK5784283, Placebo, Standard of Care - Nasal Polyps	Phase 3	Recruiting	GlaxoSmithKline	218	2026-09-28	2026-10-14
A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) GSK5784283, Placebo, Standard of Care - Nasal Polyps	Phase 3	Recruiting	GlaxoSmithKline	218	2026-09-03	2026-10-09

Narrower conditions

Paranasal Sinus Diseases (2)

Broader conditions

Nose Diseases (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Pathological Conditions, Anatomical (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Polyps (2)  ·  Respiratory Tract Diseases (2)

Interventions

Standard of Care (2)

Sponsors

GlaxoSmithKline (2)

Countries

United States (2)  ·  Australia (1)  ·  Puerto Rico (1)